Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired axonal transport contributes to neurodegeneration in a Cre-inducible mouse model of myocilin-associated glaucoma
Balasankara Reddy Kaipa, Ramesh Kasetti, Yogapriya Sundaresan, Linya Li, Sam Yacoub, J. Cameron Millar, William Cho, Dorota Skowronska-Krawczyk, Prabhavathi Maddineni, Krzysztof Palczewski, Gulab S. Zode
Balasankara Reddy Kaipa, Ramesh Kasetti, Yogapriya Sundaresan, Linya Li, Sam Yacoub, J. Cameron Millar, William Cho, Dorota Skowronska-Krawczyk, Prabhavathi Maddineni, Krzysztof Palczewski, Gulab S. Zode
View: Text | PDF
Research Article Genetics Neuroscience Ophthalmology

Impaired axonal transport contributes to neurodegeneration in a Cre-inducible mouse model of myocilin-associated glaucoma

  • Text
  • PDF
Abstract

Elevation of intraocular pressure (IOP) due to trabecular meshwork (TM) dysfunction, leading to neurodegeneration, is the pathological hallmark of primary open-angle glaucoma (POAG). Impaired axonal transport is an early and critical feature of glaucomatous neurodegeneration. However, a robust mouse model that accurately replicates these human POAG features has been lacking. We report the development and characterization of a new Cre-inducible mouse model expressing a DsRed-tagged Y437H mutant of human myocilin (Tg.CreMYOCY437H). A single intravitreal injection of HAd5-Cre induced selective MYOC expression in the TM, causing TM dysfunction, reducing the outflow facility, and progressively elevating IOP in Tg.CreMYOCY437H mice. Sustained IOP elevation resulted in significant loss of retinal ganglion cells (RGCs) and progressive axonal degeneration in Cre-induced Tg.CreMYOCY437H mice. Notably, impaired anterograde axonal transport was observed at the optic nerve head before RGC degeneration, independent of age, indicating that impaired axonal transport contributes to RGC degeneration in Tg.CreMYOCY437H mice. In contrast, axonal transport remained intact in ocular hypertensive mice injected with microbeads, despite significant RGC loss. Our findings indicate that Cre-inducible Tg.CreMYOCY437H mice replicate all glaucoma phenotypes, providing an ideal model for studying early events of TM dysfunction and neuronal loss in POAG.

Authors

Balasankara Reddy Kaipa, Ramesh Kasetti, Yogapriya Sundaresan, Linya Li, Sam Yacoub, J. Cameron Millar, William Cho, Dorota Skowronska-Krawczyk, Prabhavathi Maddineni, Krzysztof Palczewski, Gulab S. Zode

×

Figure 8

Anterograde axonal transport remains intact despite RGC degeneration in ocular hypertensive mice injected with microbeads.

Options: View larger image (or click on image) Download as PowerPoint
Anterograde axonal transport remains intact despite RGC degeneration in ...
Four-month-old C57BL/6 mice were injected intracamerally with PBS or microbeads (MB). Glaucoma phenotypes and anterograde axonal transport mechanisms were investigated. (A) IOP measurements revealed significant and sustained IOP elevation in MB-injected mice starting from the first week of injection. Note that only ~50% of eyes injected with MB exhibited the expected IOP elevation; i.e., ≥ 4 mm Hg. The graph only includes eyes that showed sustained IOP elevation of 4 mm Hg or more. (n = 10 for control, n = 7 MB; analyzed by 2-way ANOVA with multiple comparisons; ****P < 0.0001). (B) PERG measurements demonstrated a significant functional loss of RGCs at 6 weeks after MB injection (n = 8 control, n = 6 MB; unpaired t test, 2-tailed, mean ± SEM, ***P = 0.0002). (C) Analysis of RGCs by RBPMS staining of retinal whole mounts revealed a significant loss of RGCs at 6 weeks after MB injection (n = 4 for control, n = 3 MB; analyzed by 2-WAY ANOVA with multiple comparisons, ****P < 0.0001). (D and E) Representative images of CTB fluorescence in the optic nerve and SC, and analysis of CTB fluorescence in ocular hypertensive mice 4 weeks after MB injection. CTB transport remained intact despite significant RGC loss in MB-injected mice (n = 4 in each group; unpaired t test). Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts